GlassScriptPhysician profile
Sarah A Merrill
NPI 1740379023
$1,296.93
in general payments reported to CMS, 2019-2025
15 companies · $260 in 2025
The $260 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $42.15 · 2021: $58.91 · 2022: $211 · 2023: $37.97 · 2024: $142 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $421.91 | 2019-2025 | Tryptyr, Clareon, Clareon Panoptix Pro |
| Rxsight INC | $186.31 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $145.62 | 2019 | |
| Kala Pharmaceuticals, INC. | $141.12 | 2019 | |
| Bioventus LLC | $86.20 | 2024 | Durolane |
| Bausch & Lomb Americas INC. | $59.30 | 2023-2025 | Infuse, Miebo |
| Abbvie INC. | $58.82 | 2024-2025 | |
| Eyepoint US, INC. | $41.85 | 2019 | |
| Dompe US, INC. | $37.00 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $35.68 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $19.51 | 2025 | Xdemvy |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Lensar, INC. | $15.92 | 2019 | |
| Sun Pharmaceutical Industries INC. | $15.91 | 2019 | |
| Allergan, INC. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Merrill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.